Community Neutrophil-to-Lymphocyte Ratio Can Predict Future Cardiovascular and Cardiac-related Mortality after the First Hospitalized COPD Exacerbation.

Community NLR can be used to identify patients at increased risk of cardiovascular events following AECOPD, together with other risk factors. Every effort should be made to reduce exacerbation risk, and target intervention to those patients at highest risk.